CCL2



CCL2

Q1QQ1P2PP2D3DD3A4AA4V5VV5N6NN6A7AA7P8PP8L9LL9T10TT10C11CC11C12CC12Y13YY13S14SS14F15FF15T16TT16G17GG17K18KK18M19MM19I20II20P21PP21M22MM22S23SS23R24RR24L25LL25E26EE26N27NN27Y28YY28K29KK29R30RR30I31II31T32TT32S33SS33S34SS34R35RR35C36CC36P37PP37K38KK38E39EE39A40AA40V41VV41V42VV42F43FF43V44VV44T45TT45K46KK46L47LL47... and 78 more residue(s)...... and 78 more residue(s)

SMILES None
InChIKey None
Sequence QPDAVNAPLTCCYSFTGKMIPMSRLENYKRITSSRCPKEAVVFVTKLKREICADPNKEWVQKYIRKLDQNQVRSETTVFYKIASTLRTSAPLNVNLTHKSEANASTLFSTTTSSTSVEVTSMTEN

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections


No bioactivity data available.

CCL2

Q1QQ1P2PP2D3DD3A4AA4V5VV5N6NN6A7AA7P8PP8L9LL9T10TT10C11CC11C12CC12Y13YY13S14SS14F15FF15T16TT16G17GG17K18KK18M19MM19I20II20P21PP21M22MM22S23SS23R24RR24L25LL25E26EE26N27NN27Y28YY28K29KK29R30RR30I31II31T32TT32S33SS33S34SS34R35RR35C36CC36P37PP37K38KK38E39EE39A40AA40V41VV41V42VV42F43FF43V44VV44T45TT45K46KK46L47LL47... and 78 more residue(s)...... and 78 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections


Compound is not listed as a drug.